Crinetics Pharmaceuticals, Inc. Quarterly Common Stock, Shares Authorized from Q4 2017 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Crinetics Pharmaceuticals, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2017 to Q3 2024.
  • Crinetics Pharmaceuticals, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 200M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 200M 0 0% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 200M 0 0% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 200M 0 0% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 200M 0 0% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 200M 0 0% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 200M 0 0% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 200M 0 0% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 200M 0 0% Dec 31, 2022 10-K 2024-02-28
Q3 2022 200M 0 0% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 200M 0 0% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 200M 0 0% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 200M 0 0% Dec 31, 2021 10-K 2023-02-28
Q3 2021 200M 0 0% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 200M 0 0% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 200M 0 0% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 200M 0 0% Dec 31, 2020 10-K 2022-03-30
Q3 2020 200M 0 0% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 200M 0 0% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 200M 0 0% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 200M 0 0% Dec 31, 2019 10-K 2021-03-30
Q3 2019 200M 0 0% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 200M +135M +208% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 200M Mar 31, 2019 10-Q 2019-05-13
Q4 2018 200M +150M +296% Dec 31, 2018 10-K 2020-03-09
Q3 2018 200M Sep 30, 2018 10-Q 2018-11-13
Q2 2018 65M Jun 30, 2018 10-Q 2018-08-30
Q4 2017 50.5M Dec 31, 2017 10-K 2019-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.